PD-L1 expression as a negative predictive biomarker in advanced esophageal squamous-cell cancer treated with chemotherapy alone
Background: Programmed death-ligand 1 (PD-L1) expression is a well-established positive predictive biomarker for response to immunotherapy in advanced esophageal squamous-cell carcinoma (aESCC). However, the association between PD-L1 and response to chemotherapy alone remains unclear. This study aim...
Saved in:
| Main Authors: | M. Sachdeva, J.J. Zhao, K.X. Zhu, D.T.W. Yap, N.Z.H. Wong, N.B. Kumarakulasinghe, J. Tey, R. Sundar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | ESMO Gastrointestinal Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949819824000700 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant chemotherapy with or without PD-1/PD-L1 inhibitors in resectable esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials
by: Ye Zhang, et al.
Published: (2025-05-01) -
Predicting pathological response of resectable esophageal squamous cell carcinoma to neoadjuvant anti-PD-1 with chemotherapy using serum inflammation indexes
by: Peng Song, et al.
Published: (2025-07-01) -
sPD-1/sPD-L1 proteins in non-small cell lung cancer and esophageal squamous cell carcinoma
by: I. S. Stilidi, et al.
Published: (2022-10-01) -
PD‐1/PD‐L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First‐Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study
by: Riqing Huang, et al.
Published: (2025-03-01) -
Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
by: Jie Hu, et al.
Published: (2024-09-01)